Table 1 Characteristics of the patients with recurrent mucinous ovarian cancer compared to other histological subtypes at the time of initial diagnosis of ovarian cancer.
Mucinous | Other histotypes | p | |
|---|---|---|---|
Number of patients | 20 | 388 | |
Age (years) | 20 | 384 | n.s.* |
Mean (± s.d.) | 54.9 ± 12.5 | 57.7 ± 10.8 | |
median | 55 | 57 | |
range | 25–71 | 31–94 | |
FIGO stage at diagnosis | 20 | 383 | |
I | 20.0% | 6.5% | 0.0258** |
II | 10.0% | 7.3% | |
III | 65.0% | 77.0% | |
IV | 5.0% | 9.1% | |
Grading | 12 | 348 | |
1 | 25.0% | 3.4% | 0.0056** |
2 | 16.7% | 24.7% | |
3 | 58.3% | 71.8% | |
Result of cytoreductive surgery | 15 | 319 | |
No residual disease | 46.7% | 26.0% | n.s.** |
Optimal (≤ 1 cm residual disease) | 20.0% | 29.5% | |
Suboptimal (> 1 cm residual disease) | 33.3% | 44.5% | |
ECOG performance status | 15 | 347 | |
0 | 60.0% | 68.3% | n.s.** |
1 | 33.3% | 26.5% | |
2 | 6.7% | 4.3% | |
3 | . | 0.9% | |
Type of first line chemotherapy | 20 | 338 | n.s.*** |
Platinum single agent | 15.0% | 11.1% | |
Platinum based combinations | 85.0% | 88.9% |